Clinical Trial Update: Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial update on an arginase-1 peptide vaccine in patients with metastatic solid tumors, including non-small cell lung cancer and urothelial carcinoma; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cancer
• Colorectal Cancer
• Malignant Melanoma
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Squamous Cell Carcinoma of the Head and Neck
• Urothelial Carcinoma

Drugs mentioned

• Arginase-1 peptide vaccine (arginase-1 peptide vaccine)

Snippet

Sponsor: Herlev Hospital | Conditions: Non Small Cell Lung Cancer, Urothelial Carcinoma | Phase 1 | Status: COMPLETED | Results posted: 2023-02-28